HEALTHTHE HILL
What to know about the temporary Medicare GLP-1 Bridge program
Starting in July, Medicare beneficiaries can access GLP-1 medications via a temporary program with a flat monthly fee. The program, set to run until 2027, faces operational uncertainties ahead of its launch.
Mentioned
Related Signal
Adjacent reporting
- STAT+: Trump’s obesity drug plan creates a temporary Medicare program that may be hard to end
- Medicare launches pilot program expanding access to GLP-1 drugs
- Medicare launches pilot program expanding access to GLP-1 drugs
- A New Medicare Option for Weight Loss Drugs: What Older Americans Should Know
- Lilly’s GLP-1 medications will soon be covered by CVS, potentially opening access for millions of Americans
- STAT+: Medicare still won’t say how much covering obesity drugs will cost